Clinical Trials Browser

Active not recruiting × Glioblastoma × TVB-2640 × Clear all

NCT05118776 2024-10-31

Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

Phase 3 Active not recruiting

Glioblastoma